MithunVShahMDPhD

Oncology • Rochester, MN

Hematologic Oncology

Hematologist, Mayo Clinic Comprehensive Cancer Center in Rochester, Minnesota

Join to view full profile

Dr. Shah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shah's full profile

Already have an account?

Office
200 1st Street SW
Rochester, MN 55905

Summary

Dr. Mithun Shah is an oncologist in Rochester, MN, specializing in Hematologic Oncology. He completed his residency in Internal Medicine at Penn State Milton S Hershey Medical Center from 2010 to 2013. Subsequently, he undertook a fellowship in Hematology and Medical Oncology at Mayo Clinic College of Medicine and Science between 2013 and 2017. Dr. Shah's clinical expertise includes conducting bone marrow biopsies and aspirations. Among his publications, prominent ones include research articles published in reputed journals such as JAMA Oncology, Blood Advances, British Journal of Haematology, Haematologica, and Bone Marrow Transplantation.

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2013 - 2017
Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 2010 - 2013
B. J. Medical College AhmedabadClass of 2002

Certifications & Licensure

MN State Medical License 2013 - 2025
PA State Medical License 2010 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.
Naseema Gangat, Azeem Elbeih, Nour Ghosoun, Kristen McCullough, Fnu Aperna
American Journal of Hematology. 2024-12-13
Characterisation and prognostic impact Of ZRSR2 mutations in myeloid neoplasms.
Mahmoud Yacout, Bahga Katamesh, Yazan Jabban, Rong He, David Viswanatha
Leukemia. 2024-12-01
What have we learned about TP53-mutated acute myeloid leukemia?
Moazzam Shahzad, Muhammad Kashif Amin, Naval G Daver, Mithun Vinod Shah, Devendra Hiwase
Blood Cancer Journal. 2024-11-19

Journal Articles

Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction Drugs
Krina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature

Abstracts/Posters

Acute Myeloid Leukemia with High Risk Features: Routine Central Nervous System Evaluation May be Beneficial
Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Clinical Features and Outcomes of Unifocal Adult Langerhans Cell Histiocytosis
Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Characteristics and Outcomes of Therapy Related Myeloid Neoplasms in Patients with Multiple Myeloma Following Autologous Stem Cell Transplantation
Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Molecular Alterations in Adult Histiocytic Neoplasms
Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Survival Outcomes Following Allogeneic Stem Cell Transplantation for Inherited Bone Marrow Failure and Myeloid Germline Predisposition Syndromes
Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Flurabine Improves Transplant Outcomes in Older MDS Patients
Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for Lymphoma
Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Single-Agent Cladribine As an Effective Therapy for Adults with Langerhans Cell Histiocytosis
Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all

Lectures

Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018